CD4+CD25high regulatory T cells in human autoimmune diabetes

被引:162
作者
Putnam, AL
Vendrame, F
Dotta, F
Gottlieb, PA
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA
[2] Univ Roma La Sapienza, Dept Clin Sci Endocrinol, Rome, Italy
[3] Univ Siena, Dept Internal Med & Endocrine & Metabol Sci, I-53100 Siena, Italy
关键词
type I diabetes; regulatory cells;
D O I
10.1016/j.jaut.2004.11.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In mouse models, CD4(+)CD25(+) T cells are involved in maintenance of peripheral tolerance. In humans, a subset of CD4+CD25+ T cells expressing high levels of CD25 (CD4(+)CD25(high)) with characteristics identical to murine CD4(+)CD25(+) was recently described. We evaluated the characteristics of CD4(+)CD25(high) T cells in peripheral blood of type 1 diabetic subjects (T1D) and normal controls (NC). In contrast to a previous report, we found no difference in the number of CD4(+)CD25(high) and CD4(+)CD25(+) T cells between T1D and NC. We confirmed previous studies that demonstrated that human CD4(+)CD25(high) cells can suppress the proliferation of co-cultured CD4(+)CD25(-) cells stimulated in conditions of sub-maximal cross-linking by anti-CD3 either with or without anti-CD28. However, we did not observe statistical differences between the normal controls and the chronic diabetic subjects we tested. Culturing of these cell populations did not appear to affect their ability to suppress proliferation in both groups. In conclusion, we found no significant differences in number or in vitro regulatory function of CD4(+)CD25(high) in chronic human T1D subjects. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 31 条
[1]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[2]   ORGAN-SPECIFIC AUTOIMMUNITY [J].
BACH, JF .
IMMUNOLOGY TODAY, 1995, 16 (07) :353-355
[3]   Inhibition of human CD4+CD25+high regulatory T cell function [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2002, 169 (11) :6210-6217
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]  
Chai JG, 2002, EUR J IMMUNOL, V32, P2365, DOI 10.1002/1521-4141(200208)32:8<2365::AID-IMMU2365>3.0.CO
[6]  
2-2
[7]   CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis [J].
de Kleer, IM ;
Wedderburn, LR ;
Taams, LS ;
Patel, A ;
Varsani, H ;
Klein, M ;
de Jager, W ;
Pugayung, G ;
Giannoni, F ;
Rijkers, G ;
Albani, S ;
Kuis, W ;
Prakken, B .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6435-6443
[8]   Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood [J].
Dieckmann, D ;
Plottner, H ;
Berchtold, S ;
Berger, T ;
Schuler, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :1303-1310
[9]   PATHOGENESIS OF MULTIPLE-SCLEROSIS [J].
FFRENCHCONSTANT, C .
LANCET, 1994, 343 (8892) :271-275
[10]   The initiation of autoimmune diabetes [J].
Green, EA ;
Flavell, RA .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :663-669